Mendel Money Management Regeneron Pharmaceuticals, Inc. Transaction History

Mendel Money Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$902.69 - $993.35 $902 - $993	1 Added 0.37%	273 $262,000
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $210,848 - $239,822	272 New	272 $238,000
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $6,804 - $8,269	-10 Reduced 3.33%	290 $238,000
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $2,823 - $3,065	-4 Reduced 1.32%	300 $216,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $174,486 - $220,193	304 New	304 $209,000
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $168,343 - $226,823	-307 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $182,701 - $214,418	307 New	307 $214,000

1,464

84.4M

907K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $109B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Mendel Money Management, based on Form 13F filings with the SEC.

Stay updated on Mendel Money Management with notifications on news.